{"nctId":"NCT00362232","briefTitle":"Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Vein Thromboembolism (DVT) and Pulmonary Embolism (PE). A Study of BAY59-7939 in the Prevention of Venous Thrombo Embolism (VTE) in Subjects Undergoing Elective Total Knee Replacement.","startDateStruct":{"date":"2006-06"},"conditions":["Venous Thromboembolism"],"count":3148,"armGroups":[{"label":"Rivaroxaban 10 mg Once Daily (OD) ((Xarelto, BAY59-7939))","type":"EXPERIMENTAL","interventionNames":["Drug: Rivaroxaban (Xarelto, BAY59-7939)","Drug: Placebo: syringes of Enoxaparin"]},{"label":"Enoxaparin 30 mg twice a day (bid)","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Enoxaparin","Drug: Placebo: tablet of Rivaroxaban"]}],"interventions":[{"name":"Rivaroxaban (Xarelto, BAY59-7939)","otherNames":[]},{"name":"Enoxaparin","otherNames":[]},{"name":"Placebo: tablet of Rivaroxaban","otherNames":[]},{"name":"Placebo: syringes of Enoxaparin","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male and female patients aged 18 years or above\n* Patients scheduled for elective total knee replacement\n\nExclusion Criteria:\n\n* Active bleeding or high risk of bleeding contraindicating treatment with Low Molecular Weight Heparin (LMWH)\n* Contraindication listed in the labeling or conditions precluding subject treatment with enoxaparin or requiring dose adjustment (e.g. severe renal impairment, please refer to the local label of enoxaparin in your country)\n* Conditions prohibiting bilateral venography (e.g. amputation of 1 leg, allergy to contrast media)","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Composite Endpoint of Total Venous Thrombo Embolism (VTE) i.e.: Any Deep Vein Thromboembolism (DVT) (Proximal and/or Distal), Non Fatal Pulmonary Embolism (PE), Death of All Causes Per Protocol Population","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of deep vein thrombosis (DVT) and pulmonary embolism (PE), ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.71","spread":null},{"groupId":"OG001","value":"9.34","spread":null}]}]}]},{"type":"PRIMARY","title":"Composite Endpoint of Total VTE i.e.: Any DVT (Proximal and/or Distal), Non Fatal PE, Death of All Causes Per Modified Intent to Treat Population.","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of deep vein thrombosis (DVT) and pulmonary embolism (PE), ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.94","spread":null},{"groupId":"OG001","value":"10.11","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of the Composite Endpoint Comprising Proximal DVT, Non-fatal PE and VTE- Related Death (Major VTE) Per Protocol Population of Major VTE","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of deep vein thrombosis (DVT) and pulmonary embolism (PE), ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.09","spread":null},{"groupId":"OG001","value":"1.47","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of the Composite Endpoint Comprising Proximal DVT, Non-fatal PE and VTE- Related Death (Major VTE) Per Modified Intent to Treat Population of Major VTE.","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of deep vein thrombosis (DVT) and pulmonary embolism (PE), ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.16","spread":null},{"groupId":"OG001","value":"1.98","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Symptomatic VTE (DVT, PE) Per Protocol Population.","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of DVT and PE, ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.04","spread":null},{"groupId":"OG001","value":"1.48","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Symptomatic VTE (DVT, PE) Per Modified Intent to Treat Population.","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of DVT and PE, ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.14","spread":null},{"groupId":"OG001","value":"1.88","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of DVT (Proximal, Distal) Per Protocol Population.","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of DVT and PE, ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.37","spread":null},{"groupId":"OG001","value":"8.66","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of DVT (Proximal, Distal) Per Modified Intent to Treat Population.","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of DVT and PE, ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.32","spread":null},{"groupId":"OG001","value":"8.97","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Symptomatic VTE During Follow-up Per Protocol Population.","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of DVT and PE, ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.35","spread":null},{"groupId":"OG001","value":"0.11","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of Symptomatic VTE During Follow-up Per Modified Intent to Treat Population.","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of DVT and PE, ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.31","spread":null},{"groupId":"OG001","value":"0.21","spread":null}]}]}]},{"type":"SECONDARY","title":"The Composite Endpoint Comprising Major VTE and Treatment-emergent Major Bleeding Per Subjects Valid for Analysis of Net Clinical Benefit","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of DVT and PE, ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography, anesthesia and surgery reports, number of transfusions","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2.04","spread":null},{"groupId":"OG001","value":"2.33","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of the Composite Endpoint That Results From the Primary Endpoint by Substituting VTE Related Death for All Death Per Protocol Population.","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of DVT and PE, ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.71","spread":null},{"groupId":"OG001","value":"9.11","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of the Composite Endpoint That Results From the Primary Endpoint by Substituting VTE Related Death for All Death Per Modified Intent to Treat Population.","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of DVT and PE, ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.84","spread":null},{"groupId":"OG001","value":"9.80","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of the Composite Endpoint That Results From Major VTE by Substituting All Cause Mortality for VTE-related Death Per Protocol of Major VTE Population.","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of DVT and PE, ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.09","spread":null},{"groupId":"OG001","value":"1.67","spread":null}]}]}]},{"type":"SECONDARY","title":"Incidence of the Composite Endpoint That Results From Major VTE by Substituting All Cause Mortality for VTE-related Death Per Modified Intent to Treat of Major VTE Population.","description":"Blinded, adjudicated assessment of bilateral venography, clinical signs of DVT and PE, ultrasound, clinical chemistry and coagulation factors, autopsy report, electrocardiogram (ECG), pulmonary angiography, perfusion/ventilation lung scintigraphy, chest radiography, computed tomography","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.25","spread":null},{"groupId":"OG001","value":"2.25","spread":null}]}]}]},{"type":"SECONDARY","title":"Treatment-emergent Major Bleedings Per Safety Population.","description":"Blinded, adjudicated assessments of all available information (eg, anesthesia and surgery reports, laboratory results, number of transfusions, autopsy report)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.66","spread":null},{"groupId":"OG001","value":"0.27","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":106,"n":1526},"commonTop":["Pyrexia","Nausea","Constipation","Oedema peripheral","Anaemia postoperative"]}}}